BurgusR, DunnRF, DesiderioD, GuilleminR. 1969. Structure moleculaire du facteur hypothalamique hypophysiotrope TRF d' origine ovine: evidence par spectometrie de masse de la sequence PGA-His-Pro-NH2. CR Acad Sci (Paris)., 269:1870–1873.
2.
BolerJ, EnzmannF, FolkersK, BowersCY, SchallyAV. 1969. The identity of chemical and hormonal properties of the thyrotropin releasing hormone and pyroglutamyl-histidyl-proline amide. Biochem Biophys Res Commun, 37:705–710.
3.
HarrisGW. 1948. Neural control of the pituitary gland. Physiol Rev, 28:134–141.
4.
AndersonMS, BowersCY, KastinAJ, SchalchDS, SchallyAV, SnyderPJ, UtigerED, WilberJF, WiseAJ. 1971. Synthetic thyrotropin-releasing hormone. A potent stimulator of thyrotropin—secretion in man. New Engl J Med, 285:1279–1283.
FleischerN, LorenteM, KirklandR, KirklandR, ClaytonG, CalderonM. 1972. Synthetic thyrotropin releasing factor as a test of pituitary thyrotropin reserve. J Clin Endocrinol Metab, 34:617–624.
7.
CarlsonHE, HershmanJM. 1975. The hypothalamic-pituitary-thyroid axis. Med Clin North Am, 59:1045–1053.
8.
SeidstickerB. 1982SeidstickerB. Palintonos Harmonia. Hypomnemata. Heft 72. Studien zu kom. Elementen in d.griech. Tragoedie. Vandenhoeck and Rupprecht Verlag: Goettingen, Germany, 279.
9.
ScanlonMF, PetersJR, SalvadorJ, RichardsSH, JohnR, HowellS, WilliamsED, ThomasJP, HallR. 1986. The preoperative and postoperative investigation of TSH and prolactin release in the management of patients with hyperprolactinemia due to prolactinomas and nonfunctional pituitary tumors: relationship to adenoma size. Clin Endocrinol (Oxf ), 24:435–446.
10.
IrieM, TsushimaTJ. 1972. Increase of serum growth hormone concentration following thyrotropin releasing hormone injection in patients with acromegaly or gigantism. J Clin Endocrinol Metab, 35:97–100.
11.
PopovicV, DamjanovicS. 1998. The effect of thyrotropin-releasing hormone on gonadotropin and free α-subunit secretion in patients with acromegaly and functionless pituitary tumors. Thyroid, 8:935–939.
12.
EmersonCH. 1985. Central hypothyroidism and hyperthyroidism. Med Clin North Am, 69:1019–1034.
13.
FagliaG. 1998. The clinical impact of the thyrotropin-releasing hormone test. Thyroid, 8:903–908.
14.
FliersE, WiersingaWH, SwaabDF. 1998. Physiological and pathophysiological aspects of thyrotropin-releasing hormone gene expression in the human hypothalamus. Thyroid, 8:921–928.
15.
FeketeC, LechanRM. 2007. Negative feedback regulation of hypophysiotropic thyrotropin-releasing hormone (TRH) synthesizing neurons: role of neuronal afferents and type 2 deiodinase. Front Neuroendocrinol, 28:97–114.
16.
LechanRM, FeketeC. 2006. The TRH neuron: a hypothalamic integrator of energy metabolism. Prog Brain Res, 153:209–235.
17.
YamadaM, MoriM. 2002. Congenital central hypothyroidism due to mutation of the thyrotropin-releasing hormone receptor gene. Nippon Rinsho, 60:277–283.
18.
BonomiM, BusnelliM, Beck-PeccozP, CostanzoD, AntonicaF, DolciC, PilottaA, BuziF, PersaniL. 2009. A family with complete resistance to thyrotropin-releasing hormone. N Engl J Med, 360:731–734.
19.
UmezawaR, YamadaM, HoriguchiK, IshiiS, HashimotoK, OkadaS, SatoT, MoriM. 2009. Aberrant histone modifications at the thyrotropin-releasing hormone gene in resistance to thyroid hormone: analysis of F455S mutant thyroid hormone receptor. Endocrinology, 150:3425–3432.
